Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksCAPLIPOINT
resources
CAPLIPOINT

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT
BSE: 524742
Sector: Healthcare
Industry: Pharmaceuticals
2,612.20-59.3 (-2.22%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Caplin Point Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results———————
Conference Calls—————————
Presentations————————————

Corporate Announcements and Regulatory Filings

Caplin Point Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201811 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended June 30, 2026
  • Closure of Trading Window27 Jun 2026
    Closure of Trading Window
    Intimation of closure of Trading Window commencing from July 01, 2026
  • Newspaper Publication22 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisement for transfer of Unclaimed dividend and shares to IEPF
  • Reg.24(A)-Annual Secretarial Compliance29 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance report for the year ended March 31, 2026
  • Analyst / Investor Meet22 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Analyst / Investor Meet14 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Earnings call for Q4(2025-26)
  • Press Release / Media Release14 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release regarding receipt of final approval by our subsidiary, Caplin Steriles Limited, from USFDA, for Foscarnet Sodium Injection
  • Dividend14 May 2026
    Corporate Action-Board approves Dividend
    The Board at its meeting held today, May 14, 2026, had declared Interim Dividend of INR.4.00 (200%) per equity share for the FY 2025-26 and fixed the Record date as May 30, 2026.
  • Outcome of Board Meeting14 May 2026
    Board Meeting Outcome for For Meeting Held On May 14, 2026
    The Board at its meeting held today, May 14, 2026, had 1. Approved the Audited standalone and consolidated financial results of the Company for the year ended March 31, 2026, along with ....
  • Analyst / Investor Meet7 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Q4 post-results conference call invite is enclosed herewith.
  • Board Meeting7 May 2026
    Board Meeting Intimation for Approval Of Financial Results And Declaration Of Interim Dividend, If Any, Approved By The Board.
    Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited financial ....
  • Press Release / Media Release5 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from USFDA for Calcium Gluconate Injection USP
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Intimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
  • Closure of Trading Window27 Mar 2026
    Closure of Trading Window
    Intimation of closure of Trading Window commencing from April 01, 2026
  • Press Release / Media Release13 Mar 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release regarding receipt of final approval by our subsidiary, Caplin Steriles Limited, from USFDA for the Potassium Phosphates Injection USP
  • Cessation3 Mar 2026
    Announcement under Regulation 30 (LODR)-Cessation
    Cessation of Dr. C K Gariyali as an Independent Director of the Company with effect from March 3, 2026.
  • Press Release / Media Release28 Feb 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from USFDA for the Desmopressin Acetate Injection USP
  • Press Release / Media Release24 Feb 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP
  • Analyst / Investor Meet5 Feb 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Results - Analyst/Investor Meet - Earnings Call - Q3(2025-2026) - Audio Recording
  • Outcome of Board Meeting5 Feb 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of the Board Meeting held on February 05, 2026

Frequently Asked Questions

Where can I download the annual report of Caplin Point Laboratories Ltd.?
Annual reports of Caplin Point Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Caplin Point Laboratories Ltd.?
Quarterly earnings results and presentations of Caplin Point Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Caplin Point Laboratories Ltd. publish earnings call transcripts?
Earnings call transcripts of Caplin Point Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Caplin Point Laboratories Ltd.?
Investor presentations and annual day presentations of Caplin Point Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Caplin Point Laboratories Ltd.?
Corporate announcements and regulatory filings of Caplin Point Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Caplin Point Laboratories Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Caplin Point Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Caplin Point Laboratories Ltd.?
The ISIN (International Securities Identification Number) of Caplin Point Laboratories Ltd. is INE475E01026. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Caplin Point Laboratories Ltd. listed?
Caplin Point Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is CAPLIPOINT and the BSE code is -.
Where can I find the shareholding pattern of Caplin Point Laboratories Ltd.?
The quarterly shareholding pattern of Caplin Point Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Caplin Point Laboratories Ltd. on Sharpely?
Share price data for Caplin Point Laboratories Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.